CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy.
CIMT
Covid19
cancer immunotherapy
cellular therapy
checkpoint blockade
combination therapy
personalized therapy
tumor microenvironment
tumor vaccination
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
31 12 2022
31 12 2022
Historique:
pubmed:
8
2
2022
medline:
9
4
2022
entrez:
7
2
2022
Statut:
ppublish
Résumé
After one year of absence, the 18th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Europe's cancer immunotherapy meeting, took place virtually from 10 to 12 May 2021. Over 850 academic and clinical professionals from 30 countries met to discuss the recent advancements in cancer immunotherapy and the current progress in COVID19-related research. This meeting report summarizes the highlights of CIMT2021.
Identifiants
pubmed: 35130105
doi: 10.1080/21645515.2021.2024416
pmc: PMC8993083
doi:
Types de publication
Congress
Langues
eng
Sous-ensembles de citation
IM
Pagination
2024416Références
Mayo Clin Proc. 2003 Jan;78(1):21-33
pubmed: 12528874
BMJ. 2021 Mar 9;372:n579
pubmed: 33687922
J Immunol. 2008 Jan 1;180(1):309-18
pubmed: 18097032
Int J Infect Dis. 2021 Jul;108:145-155
pubmed: 34022338
Science. 2014 Feb 14;343(6172):776-9
pubmed: 24531970
N Engl J Med. 2021 Jul 29;385(5):472-474
pubmed: 33979486
Nature. 2021 Apr;592(7853):283-289
pubmed: 33524990
Nat Chem Biol. 2018 Mar;14(3):317-324
pubmed: 29377003
Nanoscale. 2017 Jan 26;9(4):1575-1579
pubmed: 28067926
Nature. 2020 Sep;585(7823):107-112
pubmed: 32728218
Nature. 2021 Feb;590(7845):332-337
pubmed: 33328638
J Exp Med. 1996 Aug 1;184(2):465-72
pubmed: 8760800
Nature. 2019 Jul;571(7764):270-274
pubmed: 31207604
Gut. 2020 Apr;69(4):691-703
pubmed: 31270164
Mol Ther. 2008 Nov;16(11):1833-40
pubmed: 18797453
J Clin Invest. 2020 Dec 1;130(12):6409-6416
pubmed: 32809969
Cell. 2020 Oct 15;183(2):347-362.e24
pubmed: 33064988
Front Pharmacol. 2020 May 15;11:722
pubmed: 32528284
Science. 2006 Sep 29;313(5795):1960-4
pubmed: 17008531
Blood. 2020 Sep 17;136(12):1407-1418
pubmed: 32483603
Clin Sci (Lond). 2021 Jan 15;135(1):35-52
pubmed: 33399850
Nat Biotechnol. 2020 May;38(5):629-637
pubmed: 32152598
Blood. 2017 Mar 9;129(10):1284-1295
pubmed: 28053195
Nature. 2020 Jan;577(7791):549-555
pubmed: 31942075
Nature. 2017 Jul 13;547(7662):217-221
pubmed: 28678778
Cancer Res. 2010 Nov 15;70(22):9031-40
pubmed: 21045153
Science. 2020 Jan 24;367(6476):446-453
pubmed: 31896660
Cell Rep Med. 2021 Jul 20;2(7):100355
pubmed: 34230917
Nature. 2014 Nov 27;515(7528):572-6
pubmed: 25428506
Clin Cancer Res. 2021 May 1;27(9):2571-2583
pubmed: 33593881
N Engl J Med. 2015 Jun 25;372(26):2509-20
pubmed: 26028255
Nat Commun. 2021 Mar 5;12(1):1428
pubmed: 33674591
Nat Biotechnol. 2020 Mar;38(3):320-332
pubmed: 31932728
Cancer Sci. 2019 Jul;110(7):2080-2089
pubmed: 31102428
Nature. 2016 Jun 01;534(7607):396-401
pubmed: 27281205
J Immunother Cancer. 2019 Sep 18;7(1):255
pubmed: 31533831
Sci Transl Med. 2017 Jan 25;9(374):
pubmed: 28123068
Nat Biotechnol. 2022 Apr;40(4):488-498
pubmed: 34873326
Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):403-8
pubmed: 24344295
Nature. 2017 Jul 13;547(7662):222-226
pubmed: 28678784
Euro Surveill. 2021 Mar;26(11):
pubmed: 33739254
Immunity. 2020 Sep 15;53(3):658-671.e6
pubmed: 32937153
Cancer Discov. 2020 Nov;10(11):1758-1773
pubmed: 32651166
Clin Infect Dis. 2022 Jan 29;74(2):366-368
pubmed: 33961693
Bioeng Transl Med. 2018 Jul 27;3(2):75-86
pubmed: 30065964
Nature. 2020 Oct;586(7830):589-593
pubmed: 32785213
Nat Med. 2021 Mar;27(3):504-514
pubmed: 33603241
Lancet. 2021 Mar 20;397(10279):1075-1084
pubmed: 33743869
Nat Protoc. 2020 Apr;15(4):1507-1524
pubmed: 32103205
Front Immunol. 2021 Mar 03;12:640082
pubmed: 33746981
Clin Cancer Res. 2018 Feb 1;24(3):634-647
pubmed: 29018052
Nucleic Acids Res. 2011 Nov;39(21):e142
pubmed: 21890902
Genome Med. 2019 Dec 30;11(1):87
pubmed: 31888734
Genome Biol. 2015 Mar 31;16:64
pubmed: 25853550
Nat Commun. 2020 May 8;11(1):2283
pubmed: 32385241
Nature. 2017 May 25;545(7655):452-456
pubmed: 28514453
Science. 2021 Feb 5;371(6529):595-602
pubmed: 33542131
Cell. 2020 Aug 20;182(4):872-885.e19
pubmed: 32783915
Nature. 2021 May;593(7858):270-274
pubmed: 33723411
Science. 2015 Nov 27;350(6264):1084-9
pubmed: 26541606
Blood. 2006 Dec 15;108(13):4009-17
pubmed: 16940422
Nature. 2020 Jan;577(7791):561-565
pubmed: 31942071
N Engl J Med. 2021 Dec 23;385(26):2489-2491
pubmed: 34941024
N Engl J Med. 2017 Oct 5;377(14):1345-1356
pubmed: 28889792
Nat Med. 2021 Mar;27(3):515-525
pubmed: 33479501
Nat Immunol. 2020 Mar;21(3):298-308
pubmed: 32066953
Science. 2015 Nov 27;350(6264):1079-84
pubmed: 26541610
Science. 2018 Jan 5;359(6371):91-97
pubmed: 29097494
Cell Death Differ. 2014 Jan;21(1):5-14
pubmed: 23579243
Sci Transl Med. 2019 Jun 26;11(498):
pubmed: 31243150
Lancet Infect Dis. 2021 Nov;21(11):1507-1517
pubmed: 34171231
Science. 2021 Jan 8;371(6525):145-153
pubmed: 33414215
Cancer Immunol Res. 2016 Jun;4(6):498-508
pubmed: 27059623
Front Immunol. 2018 Jan 18;8:1807
pubmed: 29403468
Sci Transl Med. 2019 Aug 21;11(506):
pubmed: 31434757
Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):5473-8
pubmed: 25827230
Nature. 2021 Apr;592(7852):138-143
pubmed: 33731925
Cell. 2020 May 14;181(4):905-913.e7
pubmed: 32333836
Nat Commun. 2018 Dec 5;9(1):5193
pubmed: 30518925
EMBO Mol Med. 2021 Jan 11;13(1):e13426
pubmed: 33179852
Science. 2017 Jul 28;357(6349):409-413
pubmed: 28596308
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
N Engl J Med. 2020 Dec 17;383(25):2439-2450
pubmed: 33053279